Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/2012
12/26/2012CN102836380A Ant watered pill containing Chinese medicines and preparation method thereof
12/26/2012CN102836340A Pharmaceutical composition for benefiting vital energy, enriching blood and nourishing liver and kidney as well as preparation method and application thereof
12/26/2012CN102836334A Veterinary Chinese medicinal preparation for replenishing qi to invigorate spleen
12/26/2012CN102836283A 抗疲劳口服液及其制备方法 Oral anti-fatigue and its preparation method
12/26/2012CN102836262A Immunity-improving health care product
12/26/2012CN102836236A Ultrahigh-pressure extraction method of hovenia dulcis general flavone
12/26/2012CN102836194A Extraction method of affine cudweed total flavonoids
12/26/2012CN102836193A Lucid ganoderma composite spore powder and preparation method thereof
12/26/2012CN102836182A Extraction process of Ganoderma lucidum acidic components
12/26/2012CN102836181A Antradiacomphora oral liquid and preparation method thereof
12/26/2012CN102836176A Drug combination for treating allergic rhinitis or asthma as well as preparation method and application of same
12/26/2012CN102836165A Aspirin vitamin C effervescent tablet and preparation technology thereof
12/26/2012CN102836132A Methylsulfonic acid nafamostat lyophilized powder injection
12/26/2012CN102836102A Method for preparing bamboo charcoal facial cleanser
12/26/2012CN102835667A Lactic acid bacteria strain food composition and pharmaceutical composition for treating allergy
12/26/2012CN102835240A Cultivation method of selenium-enriched Codonopsis lanceolata, as well as extraction method and application of selenium-containing polysaccharide of selenium-enriched Codonopsis lanceolata
12/26/2012CN102309751B Superoxide dismutase (SOD) composite capsule and preparation method thereof
12/26/2012CN102258566B Composite Chinese herbal medicinal immunopotentiator for sea urchin
12/26/2012CN102188523B Plant antibiotic
12/26/2012CN102178935B Preparation for resisting radiation, enhancing body immunity and preventing and treating tumors
12/26/2012CN102178934B Preparation for increasing bone mineral density, preventing osteoarthrosis and enhancing immunity
12/26/2012CN102178932B Preparation for relieving fatigue and enhancing immunity
12/26/2012CN101553214B Compositions and methods for treating, controlling, reducing, ameliorating, or preventing allergy
12/26/2012CN101524377B Composite of wall-breaking lucidum spore powder and cyclodextrin and preparation method thereof
12/26/2012CN101437799B p38 MAP kinase inhibitors
12/26/2012CN101415432B A pharmaceutical composition useful as an immunomodulating agent and a process for the preparation thereof
12/26/2012CN100998864B Cyclosporin A semisolid skeleton capsule
12/25/2012US8338591 3-aryl-5,6-disubstituted pyridazines
12/25/2012US8337834 Methods of making enhanced, autologous fat grafts
12/25/2012US8337816 Comprising inhalable medicament particles having a mass median aerodynamic diameter no greater than 10 mu m and 50% of a non-respirable excipient fraction comprising low density excipient particles having an aerodynamic diameter greater than 10 mu m and a geometric diameter greater than 30 mu m
12/20/2012WO2012174522A1 Combined chemical modification of sphingosine-1-phosphate (s1p) and cxcr4 signalling pathways for hematopoietic stem cell (hsc) mobilization and engraftment
12/20/2012WO2012174455A2 Group a streptococcus multivalent vaccine
12/20/2012WO2012173217A1 Crystal of pyrroloquinolinequinone disodium salt, and method for producing same
12/20/2012WO2012173184A1 Lelia (liposome-based enzyme-linked immunoassay) technique using recombinant proteoliposomes
12/20/2012WO2012173163A1 Crushed cells and composition thereof
12/20/2012WO2012172821A1 Therapeutic agent for allergic rhinitis
12/20/2012WO2012172473A1 Cysteine protease inhibitors
12/20/2012WO2012171488A1 Coumarin derivative, pharmaceutical composition and use thereof
12/20/2012WO2012171057A1 Antibodies against g-csfr and uses thereof
12/20/2012WO2012151279A3 Induction of il-12 using immunotherapy
12/20/2012US20120322884 Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine
12/20/2012US20120322862 Aptamers to 4-1BB and Their Use in Treating Diseases and Disorders
12/20/2012US20120322860 Aptamer therapeutics useful in the treatment of complement-related disorders
12/20/2012US20120322837 Amide compound and medicinal use thereof
12/20/2012US20120322825 Aqueous liquid preparations and light-stabilized aqueous liquid preparations
12/20/2012US20120322815 Pharmaceutical composition containing a3 adenosine receptor agonist
12/20/2012US20120322814 Methods of inhibiting ire1
12/20/2012US20120322807 Stat3/5 activation inhibitor
12/20/2012US20120322795 Biarylamide inhibitors of leukotriene production
12/20/2012US20120322793 Protein kinase inhibitors
12/20/2012US20120322790 Pyrazolopiperidine Compounds As CCR1 Receptor Antagonists
12/20/2012US20120322782 Veterinary compositions
12/20/2012US20120322757 Methods for Aloe Processing
12/20/2012US20120322749 Tableted compositions containing atazanavir
12/20/2012US20120322722 Pyruvamide Compounds as Inhibitors of Dust Mite Group 1 Peptidase Allergen and Their Use
12/20/2012US20120322100 Methods for producing modified glycoproteins
12/20/2012US20120321708 Sustained-release formulations of topiramate
12/20/2012US20120321698 Inhalable pharmaceutical compositions
12/20/2012US20120321668 PEPTIDES DERIVED FROM HIV-1 gp41 TRANSMEMBRANE
12/20/2012US20120321667 T cell receptor-deficient t cell compositions
12/20/2012US20120321666 T cell therapy for b cell lymphoma
12/20/2012US20120321665 Compositions and methods for treating airway inflammatory diseases
12/20/2012US20120321662 Methods of Eliciting or Boosting a Cellular Immune Response
12/20/2012US20120321661 Recombinant Measles Virus Useful as a Bivalent Vaccine Against Measles and Malarial Infections
12/20/2012US20120321659 Hbv core antigen particles with multiple immunogenic components attached via peptide ligands
12/20/2012US20120321658 Immunogenic composition comprising s. pneumoniae polysaccharides conjugated to carrier proteins
12/20/2012US20120321652 Peptides for active anti-cytokine immunization
12/20/2012US20120321651 Anti-IGE Vaccines
12/20/2012US20120321649 Peptide Vaccines for Cancers Expressing Tumor-Associated Antigens
12/20/2012US20120321648 Use of islet glucose-6-phosphatase related protein as a diagnostic tool and therapeutic target for autoimmune diabetes
12/20/2012US20120321645 Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists, and immunotoxins
12/20/2012US20120321625 Antibodies to ox-2/cd200 and uses thereof in inhibiting immune responses
12/20/2012US20120321623 ILT3 Polypeptides and Uses Thereof
12/20/2012US20120321621 INHIBITION OF FcyR-MEDIATED PHAGOCYTOSIS WITH REDUCED IMMUNOGLOBULIN PREPARATIONS
12/20/2012US20120321603 Composition and method for stabilization and delivery of therapeutic molecules
12/20/2012US20120321600 Infant formula with probiotics and milk fat globule membrane components
12/20/2012US20120321599 Herpes virus strains
12/20/2012US20120321598 Vectors and methods for long-term immune evasion to prolong tranplant viability
12/20/2012US20120321597 Methods and compositions for regenerating connective tissue
12/20/2012US20120321590 Bridged polycyclic compounds
12/20/2012US20120321573 Compositions and methods of prophylaxis for contact dermatitis
12/20/2012US20120321565 Pharmaceutical compositions comprising 17alpha-furanylesters of 17beta-carbothiate androstanes with a muscarinic receptor antagonist
12/20/2012US20120321563 Carbonic Anhydrase Targeting Agents and Methods of Using Same
12/20/2012US20120321556 Enhanced Cytotoxicity of Anti-CD74 and Anti-HLA-DR Antibodies with Interferon-Gamma
12/20/2012US20120321554 Plexin d1 as a target for tumor diagnosis and therapy
12/20/2012US20120321553 Ultrafiltration Concentration of Allotype Selected Antibodies for Small-Volume Administration
12/20/2012CA2841416A1 Method of selecting therapeutic indications
12/20/2012CA2838981A1 Group a streptococcus multivalent vaccine
12/20/2012CA2838246A1 Antibodies against g-csfr and uses thereof
12/19/2012EP2535410A1 Aptamer to fgf2 and use thereof
12/19/2012EP2535355A2 Antibodies against CD38 for treatment of multiple myeloma
12/19/2012EP2535348A1 Applications of the protein muns and the derivates thereof
12/19/2012EP2535332A1 Sinomenine derivatives, synthetic methods and uses thereof
12/19/2012EP2535059A1 Use of compound binding to msin3b that specifically binds to neuron restrictive silencer factor (nrsf)
12/19/2012EP2535052A1 Method for producing nk cell enhancement-type blood product
12/19/2012EP2534151A1 8-methyl-1-phenyl-imidazol[1,5-a]pyrazine compounds
12/19/2012EP2534149A1 6-amino-2-{ [ (1s)-1-methylbutyl]oxy}-9-[5-(1-piperidinyl)-7,9-dihydro-8h-purin-8-one maleate
12/19/2012EP2533809A1 Lipidated antigens and use thereof for enhancing an immunological response
12/19/2012EP2533808A1 Process for producing an allergen extract
12/19/2012EP2533799A2 Methods for the use of progestogen as a glucocorticoid sensitizer
1 ... 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 ... 1172